Saraca indica Bark Extract Shows In Vitro Antioxidant, Antibreast Cancer Activity and Does Not Exhibit Toxicological Effects

Table 4

Haematological results on day 15 of oral gavage administration of 500, 1000, 1500, and 2000 mg/Kg B.Wt. of SIE to male CF rats. NS represent no statistical significant differences, when the test groups were compared to the control group.

	Parameter	Control group	500 mg/Kg B.Wt.	1000 mg/Kg B.Wt.	1500 mg/Kg B.Wt.	2000 mg/Kg B.Wt.	P value
		Mean ± SD	Mean ± SD	Mean ± SD	Mean ± SD	Mean ± SD
1	Hgb (g/dL)	13.03 ± 0.44	13.08 ± 0.259	13.28 ± 0.43	13.00 ± 0.58	13.02 ± 0.40	NS
2	T-RBC (×10^6/mm^3)	6.80 ± 0.08	6.71 ± 0.37	6.84 ± 0.41	6.73 ± 0.37	6.37 ± 0.42	NS
3	MCV (micron^3)	57.55 ± 0.96	58.36 ± 1.20	57.00 ± 1.05	58.02 ± 2.42	57.62 ± 0.54	NS
4	HCT (%)	39.00 ± 0.60	39.94 ± 1.72	39.52 ± 0.82	39.00 ± 1.30	39.06 ± 0.27	NS
5	MCH (pg)	19.23 ± 0.76	19.64 ± 0.59	19.48 ± 1.29	19.38 ± 1.00	19.20 ± 0.63	NS
6	MCHC (g/dL)	33.78 ± 0.93	33.32 ± 0.51	33.64 ± 0.80	33.40 ± 1.07	33.22 ± 0.94	NS
7	WBC ×10^3	4.30 ± 1.05	4.91 ± 1.25	4.87 ± 0.81	4.59 ± 0.97	4.47 ± 0.47	NS
8	RDW	10.60 ± 0.39	10.72 ± 0.16	10.90 ± 0.42	10.86 ± 0.54	10.56 ± 0.33	NS
9	MPV	4.47 ± 0.45	4.36 ± 0.40	4.08 ± 0.26	4.70 ± 0.26	4.47 ± 0.31	NS
10	PLT (×10^3/mm^3)	756.3 ± 40.15	710.2 ± 67.06	761.0 ± 54.66	739.2 ± 26.29	736.6 ± 56.06	NS